The global insulin delivery devices market was valued at USD 19.3 billion in 2025 and is projected to grow from USD 20.9 billion in 2026 to USD 35.2 billion by 2033, registering a CAGR of 7.8% from 2026 to 2033. North America dominated the global market in 2025, accounting for a revenue share of 40.7%. Market growth is primarily driven by the increasing global prevalence of diabetes and rising demand for advanced, convenient, and patient-friendly insulin administration solutions.

Insulin Delivery Devices Market Overview

According to Grand View Research, the global insulin delivery devices market is expected to experience steady growth through 2033, supported by technological advancements in diabetes care, increasing adoption of automated insulin delivery systems, and growing preference for minimally invasive drug administration. The integration of continuous glucose monitoring (CGM), smart insulin pens, and connected insulin pumps is further transforming diabetes management by improving treatment accuracy, patient adherence, and glycemic control.

Key Market Trends & Insights

• By product: Insulin pens dominated the market, accounting for a revenue share of 43.7% in 2025, driven by their convenience, portability, and ease of self-administration.
• By end use: The homecare segment held the leading market share in 2025, reflecting the increasing adoption of self-administered insulin therapy and home-based diabetes management.
• Regional leadership: North America dominated the global market with a 40.7% revenue share in 2025.
• Fastest-growing region: Asia Pacific is anticipated to register the highest CAGR during the forecast period, supported by the rising diabetes burden and improving access to advanced diabetes management technologies.
• Technological advancement: Integration of CGM systems, artificial pancreas systems, predictive algorithms, and smartphone connectivity is enhancing insulin delivery accuracy and treatment personalization.

Go Deeper! Ask Prism AI

about the Global insulin delivery devices market. Get instant answers to questions related to market sizing, growth drivers & their impact, and more.

Insulin Delivery Devices Market Size & Forecast

Key Market Trends Driving the Insulin Delivery Devices Industry

Technological Advancements in Insulin Delivery Systems

Technological innovation is a major factor driving the growth of the insulin delivery devices market. Manufacturers are increasingly developing advanced devices that offer improved treatment effectiveness, reduced patient discomfort, and greater personalization. The transition from conventional insulin injections to smart insulin pens, wearable insulin pumps, and automated insulin delivery systems is improving the overall diabetes management experience.

The integration of digital technologies with insulin delivery devices is further accelerating market development. Continuous glucose monitoring (CGM) systems, which provide real-time glucose measurements, are increasingly being integrated with insulin pumps to support automated insulin adjustments. These connected solutions help patients maintain better glycemic control while reducing the need for frequent manual intervention.

The evolution of insulin delivery technology has progressed through several important innovations. Insulin pens simplified self-administration and improved dosing convenience compared with traditional syringes. Subsequently, insulin pumps enabled continuous insulin infusion, supporting more consistent glucose management. The introduction of CGM devices further enhanced diabetes care by providing real-time glucose readings and valuable insights into glucose fluctuations.

These developments have contributed to the emergence of Artificial Pancreas Systems (APS), which combine CGM technology, insulin pumps, and intelligent algorithms to automate insulin delivery. By continuously analyzing glucose levels and adjusting insulin doses, these systems aim to replicate certain functions of the human pancreas and improve diabetes management.

Download a free sample report or claim your copy of this full market intelligence report

Growing Adoption of Bionic and Automated Insulin Delivery Technologies

The development of bionic and automated insulin delivery technologies is creating new opportunities in the insulin delivery devices market. These systems combine biological monitoring capabilities with artificial intelligence, sensors, algorithms, and automated pumping mechanisms to regulate blood glucose levels more effectively.

Modern insulin pumps increasingly incorporate CGM connectivity, predictive algorithms, and smartphone integration to support personalized insulin administration. These features enable devices to respond dynamically to changing glucose levels, helping users manage insulin requirements with greater precision.

Automated insulin delivery systems also help reduce the risk of glucose fluctuations, including hypoglycemia and hyperglycemia. By minimizing manual dosing requirements and providing continuous monitoring, these technologies are improving treatment convenience and supporting better patient outcomes.

Increasing Adoption of Connected Diabetes Management Solutions

The growing adoption of connected diabetes management technologies is transforming insulin therapy monitoring and administration. Smart insulin pens and connected mobile applications allow patients and healthcare professionals to track insulin dosage, administration timing, and glucose trends more efficiently. These technologies are also supporting improved medication adherence and more informed treatment decisions.

For instance, in December 2024, a study published by MDPI highlighted the benefits of integrating smart insulin pens with continuous glucose monitoring systems among pregnant women with type 1 diabetes. The study demonstrated improvements in glycemic control and time spent within the target glucose range without severe hypoglycemia. The connected system automatically recorded insulin dosage and administration timing while enabling real-time data sharing through a mobile application.

This development highlights the potential of connected insulin delivery technologies to improve treatment adherence, facilitate glucose monitoring, and optimize diabetes management outcomes.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.

Regional Insights

North America Insulin Delivery Devices Market

North America dominated the global insulin delivery devices market in 2025, accounting for 40.7% of total revenue. The region's leadership is supported by the high adoption of advanced diabetes management technologies, established healthcare infrastructure, and the presence of major medical device manufacturers. Increasing awareness of diabetes management and growing demand for connected insulin delivery solutions are also contributing to regional market growth.

The U.S. represents a major contributor to the North American market, supported by the availability of advanced insulin pumps, smart insulin pens, and CGM-integrated automated insulin delivery systems.

Asia Pacific Insulin Delivery Devices Market

Asia Pacific is expected to register the fastest CAGR during the forecast period. Growth is primarily attributed to the rising prevalence of diabetes, expanding healthcare infrastructure, increasing awareness of disease management, and improving access to advanced medical technologies. Growing healthcare investments and the increasing adoption of home-based diabetes management solutions are also expected to support regional expansion.

Explore the full list of profiled companies operating in this market with recent strategic initiatives

Key Insulin Delivery Devices Companies

The following companies are among the major participants profiled in the global insulin delivery devices market:

1. Novo Nordisk A/S
2. Sanofi
3. Eli Lilly and Company
4. Ypsomed AG
5. Medtronic
6. Insulet Corporation
7. B. Braun SE
8. Owen Mumford Ltd.

Explore our dedicated business services:

U.S. Healthcare Facility Mapping & Intelligence Platform: Get facility-level intelligence to guide smarter decisions. Sign up Today